NFO period: 14^th July – 22^nd July, 2022

Highlights of the NFO:

• Scheme type – An open ended scheme replicating / tracking the S&P BSE Healthcare Total Return Index


• Investment objective – The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.


• Product suitability – This product is suitable for investors who are seeking return that corresponds to the performance of S&P BSE Healthcare Total Return Index subject to tracking error. Long term capital growth.


• Minimum Application Amount – First investment is Rs. 500/- and in multiple of Rs. 1/- thereafter


• Plan/ Options available – The scheme does not offer any Plans/Options for investment.


• Fund Manager – Mr. Swapnil Mayekar and Mr. Abhiroop Mukherjee


• Benchmark – S&P BSE Healthcare Total Return Index